All the data presented in this review illustrate a distinct contribution of particular FOXP3+ Treg subpopulations to the suppression of tumor immunity and, consequently, to cancer progression, indicating the importance of removing/neutralizing highly suppressive terminally differentiated effector Tregs from the tumor tissue to enhance the antitumor immune responses. This evidence concerns the gene FOXP3 and neoplasm.